Featuring keynote addresses by FDA CTP Director Dr. Brian King and Office of Science's Dr. Todd Cecil, the goal of this program was to fill in the blanks with new perspectives on shared challenges, to bring fresh ideas and experience to the search for solutions, to highlight challenges that need collective and cooperative attention, and to provide the constructive feedback needed to solve problems and anticipate new challenges ahead.
top of page
bottom of page
Comments